EyePoint, which runs a Northbridge drug plant, told the state it will lay off 105 workers after its eye drug missed a key trial goal.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.